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Abstract
Background: Stem cell factor (SCF) receptor c-Kit is recognized as a key signaling molecule, which transduces
signals for the proliferation, differentiation and survival of stem cells. Binding of SCF to its receptor triggers
transactivation, leading to the recruitment of kinases and phosphatases to the docking platforms of c-Kit catalytic
domain. Tyrosine phosphatase-1 (Shp-1) deactivates/attenuates ‘Kit’ kinase activity. Whereas, Asp816Val mutation in
the Kit activation loop transforms kinase domain to a constitutively activated state (switch off-to-on state), in a
ligand-independent manner. This phenomenon completely abrogates negative regulation of Shp-1. To predict the
possible molecular basis of interaction between c-Kit and Shp-1, we have performed an in silico protein-protein
docking study between crystal structure of activated c-Kit (phosphorylated c-Kit) and full length crystal structure of
Shp-2, a close structural counterpart of Shp-1.
Findings: Study revealed a stretch of conserved amino acids (Lys818 to Ser821) in the Kit activation domain, which
makes decisive H-bonds with N-sh2 and phosphotyrosine binding pocket residues of the phosphatase. These H-
bonds may impose an inhibitory steric hindrance to the catalytic domain of c-Kit, there by blocking further
interaction of the activation loop molecules with incoming kinases. We have also predicted a phosphotyrosine
binding pocket in SH2 domains of Shp-1, which is found to be predominantly closer to a catalytic groove like
structure in c-Kit kinase domain.
Conclusions: This study predicts that crucial hydrogen bonding between N-sh2 domain of Shp-1 and Kit activation
loop can modulate the negative regulation of c-Kit kinase by Shp-1. Thus, this finding is expected to play a
significant role in designing suitable gain-of-function c-Kit mutants for inducing conditional proliferation of
hematopoietic stem cells.
Findings
Research hypothesis
The c-Kit controls major signaling cascades in hemato-
poietic stem cells. Earlier study indicated that the cataly-
tic domain of c-Kit consists of many important loop
regions, such as catalytic loop (786-796), activation loop
(810-839) and substrate-binding loop (829-837), which
play crucial role in the activation of Kit kinase domain
[1]. Transformation of c-Kit kinase domain from an
inactive to hyperactive state is reported to occur on the
basis of three distinct molecular phenomena. These are
(i) binding of ATP to glycine rich loop residues (596-
601), (ii) release of self-inhibitory interaction between
substrate binding loop and activation loop, and (iii) loss
of intramolecular H-bonds between Lys818-Asp816 and
Asn819-Asp816 [1].
Binding of stem cell factor (SCF) to its receptors trig-
gers dimerization coupled transphosphorylation of c-Kit
catalytic domain [2-4], which then emerges with a dual
phosphorylated tyrosine containing conserved motif
(Y
568V
569Y
570) in human c-Kit [5]. Interestingly, this
motif acts as a common docking site for SH2 and SH3
domain containing proteins [6]. The adaptor protein
APS, Src family of kinases and Shp-2 tyrosine phospha-
tase bind to Y
568. Similarly, Shp-1 tyrosine phosphatase
and the adaptor protein Shc bind to Y
570;w h e r e a s ,C -
terminal Src homologous kinase (Chk) and the adaptor
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568 and Y
570 [7]. Shp-1 is known as a
negative regulator of various receptors in hematopoietic
cells, including c-Kit kinase [8,9]. Shp-1 and Shp-2 share
both sequence and structural homologies [10]. Previous
studies have shown that a gain of function mutation,
Asp816 to Val816 (a molecular representative of masto-
cytosis) in Kit activation loop leads to extensive degra-
dation of Shp-1, indicating disruption of Shp-1 and c-
Kit interaction [11,12].
Though SH2 domains of both Shp-1 and Shp-2 are
known to interact with c-Kit, the molecular basis of this
interaction has not been elucidated. The present study
suggests some important residues in Kit activation loop
and N-sh2 domain that play crucial role in negative reg-
ulation of c-Kit kinase.
Results
Multiple sequence alignment of c-Kit kinase related
protein
Activated Kit kinase, triggered either by ligand-depen-
dent or ligand-independent manner, generates several
phosphorylated tyrosine containing docking motifs in its
juxtamembrane domain. Multiple sequence alignment
study showed a conserved regulatory motif “EEINGN-
NYVYIDP” in juxtamembrane domain of Kit kinase (Fig.
1). Further analysis of “EEINGNNYVYIDP” by Motif
scan showed a conserved dual tyrosine residue, which is
positioned as Y
568V
569Y
570 in human c-Kit (Additional
file 1). These two tyrosine residues, Y
568 and Y
570 at
positions +1 and +3 act as docking molecule for various
kinases as well as SH2 and SH3 domain containing pro-
teins. Amongst SH2 and SH3 domain containing pro-
teins epidermal growth factor receptor, platelet derived
growth factor receptor, PLCg, N/C-sh2, Abl kinase, Src
family kinases and phosphatases (Shp-1 and Shp-2) are
important [13-15]. The alignment study also revealed
deletion in the above motif (YV deleted at +1, +2 posi-
tions) in transforming tyrosine-protein kinase Kit (Swiss
prot ID P04048), normally synthesized as Gag-Kit-Pol
polyprotein. The crystal structure data of c-Kit also
expose Y
568 and Y
570 as the primary dual tyrosines to
get phosphorylated following in vitro trans-phosphoryla-
tion reaction [5]. So they predominantly act as primary
docking site in vivo to the downstream signaling mole-
cules. These two residues belong to juxtamembrane
switch motif of c-Kit (stretched in 560-571 residues)
and is also a part of auto inhibitory JMD (spanning
from 553 to 663), which makes a putative a helix. This
juxtamembrane segment in c-Kit makes a wedge that
stabilizes inactive conformation by preventing rotation
of the small kinase lobe towards the large kinase lobe to
generate active kinase conformation. Point mutations in
this motif are associated with gastrointestinal stromal
tumors, as they abolish the regulation of Kit kinase
activity [16,17]. In Gag-Kit the deletion of “YV” in
“EEINGNNYVYIDP” motif and other deleted auto-inhi-
bitory JMD residues before the same motif suggest two
possible reasons for its transformation. The first reason
could be due to the abrogation of Shp-1 mediated nega-
tive regulation, as Shp-1 can not be recruited to YVY.
The second reason may be due to change of JMD
mediated auto-inhibition of kit kinase to its hyper-acti-
vated state [18-20].
Multiple sequence alignment of the ligand: Shp-2 and
Shp-1 with SH2 domain containing proteins
To identify the crucial residues in Shp-2 and Shp-1 that
can interact with tyrosine kinases, multiple alignments
of SH2 domains of phosphatases with other SH2
domain family proteins was performed. The SH2
d o m a i n so fp 8 5s u b u n i to fP I 3k i n a s e ,L C K ,H C K ,S r c
and c-ZAP showed conserved phosphorylated tyrosine-
binding pockets (PY pockets) comprising of “FLARPS”
in N-sh2 and “FLVRES” in C-sh2 domains phosphatases
(Fig. 2). PY pockets represented three fully conserved
amino acid residues: F, L and R. The functionally impor-
tant residues in this motif initiate strong decisive inter-
actions between guanidinium group of invariant arginine
residue at a conserved position in SH2 and anionic PY
phosphate group, as shown in structure of p85 subunit
of PI3 kinase [21]. This PY pocket showed 100% conser-
vation of Phe and Arg at +1 and +4 positions, 85% con-
servation of Leu at +2 and 71% conservation of Ser at
+6 positions, respectively in N-sh2 domain containing
proteins (Fig. 2). This explains positive role of PY resi-
dues in N-sh2 domain interaction. Whereas, LCK and
HCK contain 23%, 27%, 25% and 29% conservation of
Phe, Arg, Leu and Ser at + 1, +4, +2 and +6 positions,
respectively in C-sh2 domain. The position of this PY
pocket was then identified in crystal structure of Shp-2
and displayed in Rasmol prior to docking (Additional
file 2A). The recognition of phosphorylated tyrosines in
c-Kit by SH2 domain, and binding of these tyrosine resi-
dues to SH2 domain may occur in a typical “plug and
socket” manner. It is similar to SH2 domain bound
phosphotyrosine peptides complexes, as shown by NMR
and X-ray structural studies [21,22].
Docking of Shp-2 and c-Kit cytoplasmic domain
The protein docking study was performed using acti-
vated/phosphorylated crystal structure of Kit cytoplas-
mic domain and Shp-2 (which mimics interaction of
ligand-dependent or independent activated Kit Kinase
with Shp-1 in vivo)[ 8 ] .T h eb o u n dl i g a n d - s u b s t r a t e
complexes were generated on the basis of different
r e p u l s i o nv a l u e su s e di nt h ep r o g r a m m ea n dt h eb e s t
chosen values were 6.6 and 6.4A° (Table 1). We also
plotted different repulsion values against the distances
measured between N-sh2 domain of Shp-2 and an acti-
vation loop residue Asp816 (Table 1 and Fig. 3A), as it
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Page 2 of 10Figure 1 Multiple sequence alignment of c-kit juxtamembrane domain. Multiple sequence alignment in combination with
phylogenetic tree was generated by PIR-ALN for Kit kinase with other kinase family members. Alignments show dual tyrosine containing
conserved Y
568V
569Y
570 stretch of residues in “EEINGNNYVYIDP” motif, which is used as a docking platform for SH2 and SH3 domain containing
proteins.
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Page 3 of 10plays crucial role in maintaining closed or open confor-
mation of Kit kinase domain. The data showed that
Ile571 and Val569 of “EEINGNNYV
569YI
571DPTQ”
came into close vicinity of Asp26 and Tyr100 of N-sh2
domain, whereas Asp816 stayed predominantly closer to
Tyr100 of N-sh2 by 4.7A° (Additional file 2B, 3A, 3B).
T h u sw ep r o p o s et h a tt h e r ec a nb eap o s s i b l em o d eo f
interaction between N-sh2 and activation loop residues
containing Asp816, relevant to the modulation of con-
formation in activation loop.
Checking of errors in docked complexes
Examining the substrate-bound complexes of Shp-2 is
extremely essential while determining the distances
between residues of interacting domains. The analysis
showed negligible inter-atomic clashes, zero bumping
into each other, and very few intramolecular constraints
Figure 2 Multiple sequence alignment of SH2 domains of Shp-1 and Shp-2 for analysis of PY pocket residues. SH2 domain alignment
show conserved PY pockets, such as “FLVRES” in C-sh2 and “FLARPS” in N-sh2 domains of both Shp-1 and Shp-2. Percentage of sequence
identity, conservation of residues in PY pockets as well as sh2 domains are shown as change in color intensity. PY pocket is found to be highly
conserved in N-sh2 domains, in comparison to C-sh2 domains.
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Page 4 of 10in Tyr100 of N-sh2. To verify hydrogen bonding, we
changed the torsion angle from -156.66 to -116.66
between amino group of Tyr100 and the carboxyl group
of Asn819, which showed that the hydrogen bonding of
4.76A° converted to 3.67A° (Additional file 3B).
Analysis of protein-protein interaction
The most striking feature observed in Shp-2 bound Kit
complex was the presence of a catalytic cleft like struc-
ture made of important residues, like Lys786 to Cys
788, Lys818, Asn819, His 790, Asp792, Thr847, Phe 848,
Leu 912, Thr916, Lys 918 and Tyr646, which are highly
conserved among c-Kit related kinases (Fig. 3B). These
residues were found to be in very close proximity to
Tyr100, Ala75, Gly76, Glu79, Met82, Gly83 and His85
of N-sh2, therefore expected to interact to form a stable
conformation.
Evaluation of hydrogen bonding between catalytic cleft
and SH2 domains
Shp-2 bound activated Kit kinase complex mimics the
physical interaction between autophosphorylated Kit
kinase domain with the SH2 domains of Shp-1, both
in vitro and in vivo (Fig 4A). We have detected that
certain N-sh2 terminal residues, like Ser28, Ala75,
Gly76, Glu79, Met82, Gly83, His85, Tyr100 and
Pro101 (Fig. 4B, displayed in red colored balls and
sticks) are making distinct hydrogen bonding with the
c-terminal Kit kinase lobe residues (Fig. 4B, displayed
in violet color balls and sticks). These results showed
Table 1 Residues found to be predominantly closer between N-sh2 and c-Kit
Repulsion values for docking
(A°)
Residues found closer in Shp-2 bound Kit c-
Kit: N-sh2
Distance observed c-Kit: N-
sh2 (A°)
Domains interacting
6.6 Ile571-Asp26 8.59 Kit Juxtamembrane and PY
pocket
6.6 Val569-Tyr100 7.07 Kit Juxtamembrane and N-
sh2
6.6 Asp816-Tyr100 4.68 Kit activation loop and N-sh2
6.4 Ile571-Tyr100 5.66 Kit Juxtamembrane and N-
sh2
6.4 Val569-Tyr100 4.46 Kit Juxtamembrane and N-
sh2
6.6 Asp816-Tyr100 6.17 Kit activation loop and N-sh2
Repulsion values 6.6 and 6.4 A° show that conserved Juxtamembrane residues and activation loop residues are predominantly closer to N-sh2 domain residues.
Figure 3 Analysis of predicted interactive zones of Shp-2 and c-Kit. A. Distances between interactive zones of both Shp-2 and Kit kinase
based on different repulsion values. Shp-2 bound Kit kinase complexes are generated using different repulsion values from 5.8A° to 6.6 A°.
Distance measured between Asp816 of Kit activation loop and Tyr100 of N-sh2 domain (as Tyr100 has been found to be prevalently closer to
activation loop in all models). Among the 1-6 complexes, only 6.4A° and 6.6 A° based models have activation loop residue Asp816 closest to N-
sh2 domain. B. Analysis of the catalytic cleft and the residues involved. Residues such as Cys788, Lys818 and Asn819 (orange), Thr916 and Phe
848 (blue), Thr847 and His790 (green), Asn787, Asp786 and Lys 918 (white), Lys786, Leu 912 and Tyr646 (mauve color), contribute in making a
catalytic cleft like structure in c-Kit.
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cleft make distinct hydrogen bonding with both PY
pocket and N-sh2 domain, for example Lys818 and
Asn819 with Tyr100, Asp820 with His85, and Ser821
with Met82 (Fig. 4 and Table 2). Residues from 649-
653 of N-terminal Kit kinase lobe were found to make
hydrogen bonding with the C-sh2 domain residues.
These interactions were detected specifically in sur-
rounding of c-terminal kinase groove (Fig. 4B, in
golden yellow) made of Leu783 as the tunnel-making
residue inside groove. All the hydrogen bonding
detected between conserved catalytic cleft and Kit
kinase domains are at 2-3A° in distance. The earlier
homology modeling study on Kit kinase has shown
that release of auto-inhibition of activation loop is lar-
gely dependent on the disruption of intramolecular
hydrogen bond interactions between Asp816 with the
peptide backbones of Lys818 and Asn819, which tran-
sits the activation loop into a more flexible conforma-
tion [1].
O u rs t u d ys u g g e s tt h a ts u b s e q u e n tl o s so ft h ea b o v e
intramolecular hydrogen bonding, Lys818 and Asn819
of Kit activation loop might be interacting with con-
served PY pocket residue (Ser28 and conserved Tyr100
of N-sh2 domain) for physical blocking of activation
loop motifs for further interaction.
Table 2 Hydrogen bonds detected between Kit kinase & SH2 domains
Positions of residues in substrate (Donor: c-Kit) Position of residues in Ligand (Acceptor: Shp-1) Distance of H-bonds in A°
649:ND2 192:O 2.54
649:ND2 193:O 1.12
650:N 192:O 2.03
650:ND1 195:OE1 2.11
650:ND1 195:OE2 2.07
650:NE2 195:OE2 2.98
652:N 195:OE1 1.44
652:N 195:OE2 2.64
653:N 195:OE1 2.56
655:N 200:OD1 2.04
656:N 200:OD1 2.86
671:OE2 196:O 2.27
671:OE2 199:O 2.66
775:NE2 213:O 2.18
782:N 3:OG 2.12
785:OG 3:OG 2.52
785:OG 103:OD1 2.89
802:N 211:OE1 2.27
803:N 211:O 2.68
807:NZ 197:O 2.51
807:NZ 198:O 2.53
818:NZ 28:OG 2.51
818:NZ 100:O 2.83
819:ND2 100:OH 2.50
820:O 85:NE2 2.92
821:OG 82:O 2.03
847:OG1 83:OE1 2.83
847:OG1 83:OE2 2.09
848:N 83:OE2 2.84
849:N 83:OE2 2.19
849:OE2 79:O 2.58
849:OE2 83:OE1 2.49
849:OE2 83:OE2 1.91
915:N 76:OE2 2.49
916:OG1 75:O 2.71
A: Represents hydrogen bonds between activation loop residues and N-sh2 domain residues B: Shows kinase lobe residues preceding c-terminal tail of c-Kit and
N-sh2 domain residues
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The activity of c-Kit is controlled through two impor-
tant mechanisms: either by juxtamembrane segment
auto-inhibition or by phosphatases mediated inhibition.
The c-Kit is auto-inhibited by its juxtamembrane seg-
ment as it forms a V-shaped loop, inserted directly into
the kinase lobes and displaces aC helix of Kit [23]. Sub-
sequent to the activation of Kit kinase, the intramolecu-
lar H-bonds between Lys818-Asp816 and Asn819-
Asp816 are disrupted, which further destabilizes the
activation loop, releasing the steric hindrances asso-
ciated with the rearrangement of the lobes. This phe-
nomenon allows correct positioning of residues in and
from active site, thus opening up the activated structure
of Kit kinase (Additional file 4).
On the basis of our investigation, we propose that in
activated c-Kit, the residues Lys818 and Asn819 make
intermolecular hydrogen bonding with N-sh2 domain
residues “Tyr100 and Ser28” as a result of the disruption
of intramolecular hydrogen bonding with Asp816 (Fig.
5). The constitutive change of Asp816 to Val may also
lead to deleterious effects by disrupting these H-bonds
with Lys818 and Asn819, as Asp816 has the capability to
stabilize a positively charged a h e l i c a ld i p o l eb yv i r t u eo f
negative charge in its side chain and also serving as an
amino-terminal capping to Ile817, Lys818, Asn819 and
Asp820. So a point mutation to hydrophobic or aromatic
amino acid would potentially destabilize this interaction,
thereby forcing activation loop to transit from inactive to
active confirmation, disrupting the Shp-1 association.
This leads to an enhanced ubiquitinin-mediated degrada-
tion of Shp-1 [12]. Strikingly, Asp820 signature molecule
of systemic mast cell disorder (SMCD) [represented as
Asp820Gly] forms a hydrogen bond with the His85 of N-
sh2 domain [24,25]. This also explains the role of Asp820
in Shp-1 binding. So it is considered that, Kit activation
loop residues play a critical role in Shp-1 mediated nega-
tive regulation of Kit kinase.
Conclusion
In summary, our study has revealed that certain activa-
tion loop residues in c-Kit are crucial for interaction of
kinase with Shp-1, which may play a vital role in Shp-1
mediated down-regulation of c-Kit kinase activity. We
propose that point mutation in Lys818 to Ser821 and
Thr847 to Glu849 residues in Kit catalytic domain may
lead to the generation of hyperactive functional variants
of c-Kit. These may be implicated as efficient gene ther-
apeutic candidates for conditional over-expression in the
regeneration of hematopoietic compartments.
Methods
Multiple alignments of c-Kit
Using protein information resource (PIR) based multiple
sequence alignment tool: PIR-ALN, a phylogenetic tree
and multiple sequence alignment were generated for c-
Kit and its kinase family members [26].
Motifs scan of c-kit cytoplasmic domain
Motif Scan search identified short protein sequence in
kinase domain of c-kit motifs that are either recognized
by modular signaling domains, phosphorylated by pro-
tein Ser/Thr- or Tyr-kinases or mediate specific interac-
tions with phospholipid ligands to initiate c-kit
mediated cell specific signaling [27].
Detection of phosphotyrosine binding motifs in SH2
domains of tyrosine phosphatases
The SH2 domain containing proteins were aligned using
CLUSTALW for detecting recognition and binding
Figure 4 Analysis of docked complexes and H-bond interactions between ligand and substrate (2shp-1pgk.pdb). A. The docked complex
show two SH2 domains as ribbons (pale golden color) and the blue color ball and stick structures show the residues of SH2 domains that
interacted with Kit catalytic residues (stretch of violet color). The golden color displays the groove like structure in Kit catalytic domain. B.H -
bonds are detected between SH2 domains and Kit cytoplasmic domain. Discontinuous white lines appear as the H-bonds between SH2 domain
residues (red color ball and sticks) and Kit kinase lobe (pink color ball and sticks) residues. The white background displays important hydrogen
bonding between Kit activation loop residues comprising Lys818 to Ser821 and N-sh2 domain residues.
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Page 7 of 10motif in Shp-2, which initiate recruitment of SH2
domains to Kit kinase [28].
Docking study on c-Kit and Shp-2 interactions and
visualization
We have used GRAMM (Global Range Molecular
Matching) program to generate Shp-2 bound Kit kinase
complexes and predicted H-bond interactions between
them. The principle and the methodology of GRAMM
are available at the web address http://vakser.bioinfor-
matics.ku.edu/resources/gramm/gramm1/install/readme.
pdf. Different repulsion values were applied during
docking to determine the best fit complexes (Fig. 3).
These repulsion values in A° were determined by three
factors, rij (distance between ligand and receptor), U
(energy of repulsion) and R, “range” of the potential (the
grid step) using the mathematical relationship [29,30],
as shown in the Additional file 5. Distances lesser than
10A°, between important residues (within the predicted
interactive zones), decided the best positioning of two
proteins for further analysis (Fig. 3). We have used crys-
tal structure of Shp-2 (protein tyrosine phosphatase),
2shp, a full length structural relative of Shp-1, solved at
a resolution of 2A°) [13] and activated crystal structure
of human c-Kit cytoplasmic domain (PDB: 1pkg; solved
at a resolution of 2.9A° as ligand and substrate) [5].
Analysis of models for the number of inter/intra-mole-
cular clashes, formation of hydrogen bonding and visua-
lization of model images were done by VMD
programme.
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Additional file 1: Figure S1. Motif Scan analysis of c-Kit juxtamembrane
with other kinase relatives. Tyr568 and Tyr570 of YVY motif in c-Kit
juxtamembrane domain are found to be involved in interaction with
different molecules such as EGFR kinase and CRKL binding domain, as
detected by motif scan.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-0500-3-14-
S1.TIFF]
Additional file 2: Figure S2. Analysis of Shp2 bound and unbound Kit
kinase structures. (A) The unbound form of Shp-1 displayed two sh2
domains and PY pocket. (B&C) The conserved domains like N/C-sh2, PY
pocket, Y
568V
569Y
570 and residue Tyr100 of N-sh2 domain, found to be
closer within an interactive zone, are displayed both in unbound and
bound structures of c-Kit in different colors.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-0500-3-14-
S2.TIFF]
Additional file 3: Figure S3. Detection of a catalytic groove like
structure in Kit kinase and validation of hydrogen bonding. (A) A distinct
groove like structure was found in the Shp2-Kit bound complex (shown
within a square in the center). (B) The cleft also show one H-bond
Figure 5 Hypothesis generated on basis an in silico interaction of c-Kit (PDB: 1pgk) and Shp-2 (2shp). N-sh2 domain of Shp-1 recognizes
the dual-phosphorylated tyrosines at juxtamembrane (Y
568V
569Y
570) by PY pocket. Shp-1 forms a stable complex with c-Kit kinase by making
intermolecular H-bonds with Lys818 and Asn819, using Tyr 100 and Ser28 of N-sh2 domain, following disruption of the intramolecular hydrogen
bonding of Asp816 with Lys818 and Asn819 in activated c-Kit.
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Page 8 of 10between N-sh2 domain and residue Tyr100 and Asn819 of Kit activation
loop. Change in torsion angle from -156.66 to -116.66 show the same
hydrogen bonding between the cleft and Tyr100 in a closer distance of
3.67A°.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-0500-3-14-
S3.TIFF]
Additional file 4: Figure S4. Interaction of c-Kit with various down-
stream signaling molecules. Lys818 and Asn819 make intramolecular
hydrogen bonding with Asp816 in inactive c-Kit, making a closed
conformation of c-Kit kinase. Upon binding of SCF, a chain of molecular
events take place, comprising disruption of above intramolecular H-
bonds and recruitment of tyrosine kinases and tyrosine phosphatases at
the respective phosphorylated tyrosine containing docking sites at c-Kit
catalytic domain.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-0500-3-14-
S4.TIFF]
Additional file 5: Mathematical relationship. The method for
calculating ligand-receptor interaction energy
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-0500-3-14-
S5.TIFF]
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